Cargando…

415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis

BACKGROUND: Isavuconazole (ISA) is a novel triazole antifungal approved for treating invasive aspergillosis and mucormycosis. While ISA is increasingly used for prophylaxis in hematologic malignancy patients when other azoles are contraindicated, there are currently limited data on breakthrough inva...

Descripción completa

Detalles Bibliográficos
Autores principales: DeVoe, Catherine, Fung, Monica, Schwartz, Brian, Doernberg, Sarah B, Lo, Mimi, Graff, Larissa, Tan, Marisela, Logan, Aaron, Babik, Jennifer, Chin-Hong, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253539/
http://dx.doi.org/10.1093/ofid/ofy210.426